5:59 a.m. Today5:59 a.m. Nov. 30, 2021
- By Jaimy Lee
FDA advisers to vote Tuesday on Merck's COVID-19 pill even as interest has wanedThe advisory committee will decide whether the benefits of Merck’s experimental antiviral COVID-19 pill outweigh its risks.
6:38 p.m. Nov. 28, 2021
More omicron cases pop up as world scrambles to learn more about latest COVID strainCases of the omicron variant of the coronavirus popped up in countries on opposite sides of the world Sunday and many governments rushed to close their borders even as scientists cautioned that it's not clear if the new variant is more alarming than other versions of the virus.
10:41 a.m. Nov. 28, 2021
Here's what we know about COVID omicron variant -- and what we don't know yetIt’s unclear where the new variant first emerged, but scientists in South Africa alerted the World Health Organization in recent days, and it has now been seen in travelers arriving in several countries, from Australia to Israel to the Netherlands.
9:39 a.m. Nov. 28, 2021
Vermont Is a Vaccination Star. Why Cases Are Rising There.
Northeastern states have high vaccination rates—and an uptick in cases. That could slow the economic recovery, but not as much as feared.
12:10 p.m. Nov. 27, 2021
COVID variant spreads to more countries as world on alertThe new potentially more contagious omicron variant of the coronavirus popped up in more European countries on Saturday, just days after being identified in South Africa, leaving governments around the world scrambling to stop the spread.
7:30 a.m. Nov. 27, 2021
UK plans new measures to combat omicron coronavirus variantThe U.K. government on Saturday said that it was planning new measures to combat the omicron COVID-19 variant, including mandatory PCR tests for all arriving international travelers and ramping up the use of face masks.
3:39 a.m. Nov. 26, 2021
As Europe virus cases surge, UK plows on with its new normalThe bars are shut in Vienna, and the Christmas market is empty in Munich, as several European nations tighten up or even lock down to combat a spike in coronavirus infections.
4:58 a.m. Nov. 25, 2021
Europe Set to Authorize Covid Shot for Children Above 5 Years Old
Medicine regulator says side effects of Pfizer-BioNTech shot are "usually mild or moderate"
2:38 a.m. Nov. 24, 2021
- By Alisa Wolfson
3 prominent doctors on how best to use rapid, at-home COVID tests — and which single test has ‘been shown to be very accurate’As the coronavirus delta variant continues to spread, here’s how to test for coronavirus at home.
9:44 a.m. Nov. 23, 2021
How will we make the most of an extra 30 years of life?A profound transformation in human longevity calls for momentous and creative changes in the ways we lead 100-year lives.
3:01 a.m. Nov. 22, 2021
- By Abby Schultz
J.P. Morgan Offers a “Reimagined” World for Its 2022 List of Books and ExperiencesThe annual offering of recommendations once again includes actual things to do
11:06 a.m. Nov. 19, 2021
CDC Advisory Panel Backs Pfizer and Moderna Boosters for All Adults
The move follows the FDA's approval of the booster shots for those 18 and up.
12:52 a.m. Nov. 19, 2021
Austria imposes 10-day lockdown to battle COVID, and introduce mandatory vaccinations in FebruaryAustrian Chancellor Alexander Schallenberg said the lockdown will start Monday and initially last for 10 days. Most stores will close, and cultural events will be canceled.
9:57 a.m. Nov. 18, 2021
- By Ciara Linnane
Face masks and distancing are most effective measures in reducing COVID-19 spread, study finds, as experts clamor for U.S. to expand booster programWearing a face mask and physically distancing from others are the most effective public-safety measures against the coronavirus-borne illness COVID-19 and have a statistically significant impact on reducing the spread, according to a new global study.
5:53 a.m. Nov. 17, 2021
- By Paul Brandus
Medicare may stop short at covering your eyes --- what can you do?Want to keep your vision sharp? Take a hike
4:18 a.m. Nov. 16, 2021
Pfizer Signs Deal to Aid Poor Nations' Access to Its Covid Pill
The company will allow generic drugmakers to manufacture the antiviral pill, following the lead of Merck, which announced a similar deal last month.
2:20 a.m. Nov. 16, 2021
- By Ciara Linnane
UPDATE: Pfizer to allow generics companies to make its COVID-19 oral antiviral treatment, expand access to poorer countriesPfizer Inc. said Tuesday it has signed a voluntary license agreement with United Nations-backed public health organization the Medicines Patent Pool that will allow generics makers to manufacture its COVID-19 oral antiviral treatment. The move will help expand access to the drug to low and middle-income countries. Under the terms of the main license agreement, qualified generic medicine manufacturers worldwide that are granted sub-licenses "will be able to supply PF-07321332 in combination with ritonavir to 95 countries, covering up to approximately 53% of the world's population," the company said in a statement. "This includes all low- and lower-middle-income countries and some upper-middle-income countries in Sub-Saharan Africa as well as countries that have transitioned from lower-middle to upper-middle-income status in the past five years. " Pfizer will not receive royalties on sales in those countries and will also waive royalties on sales in all countries covered by the agreement as long as COVID remains classified as a Public Health Emergency of International Concern by the World Health Organization. Pfizer said last week it would seek an emergency-use authorization for the treatment "as soon as possible." The company released data from a double-blind Phase 2/3 clinical trial in 1,219 unvaccinated adults with COVID-19 who were at high risk of severe disease and found it reduced the risk of dying or ending up in the hospital by 89%. Less than 1% of the patients who took the drug were hospitalized by the 28-day mark, compared with the 7% who received the placebo and were hospitalized or died. Participants took two pills a day for five days. Antivirals are expected to become a game changer in the pandemic, as they can be taken at home, while the current treatments are done by infusion in a clinical setting. Pfizer shares were down 0.7% premarket but have gained 35% in the year to date, while the Dow Jones Industrial Average has gained 18% and the S&P 500 has gained 25%.
7:05 a.m. Nov. 15, 2021
Booster Rollout Could Expand as Covid Cases Rise
A broader push could shore up the stocks of the vaccine makers.
5:03 p.m. Nov. 14, 2021
Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.
Successes with its Covid-19 vaccine and antiviral pill appear to validate a strategic shift by the drugmaker.
12:09 p.m. Nov. 12, 2021
- By Nicole Lyn Pesce
No, you can’t ‘undo’ a COVID vaccine with a borax bath --- but you could hurt yourselfA misleading ’detox the vaxx’ TikTok video has people bathing with a potentially dangerous cleaning agent: report
9:00 a.m. Nov. 12, 2021
- By Alisa Wolfson
Doctors reveal exactly what kind of face mask travelers should wear on the airplane to protect against COVID-19N95, KN95 or surgical mask: What face mask is right if you're worried about catching or spreading COVID while traveling?
5:44 a.m. Nov. 12, 2021
Robert Califf Is Expected to Be Nominated by Biden as FDA Commissioner
The nomination comes after a months-long search process to fill the vacant position.
11:02 p.m. Nov. 11, 2021
Missing payments or trouble calculating a tip could be early signs of dementiaResearchers found that people who developed dementia had a higher risk of skipping credit card payments starting six years before their diagnosis.
1:17 a.m. Nov. 9, 2021
- By Ciara Linnane
U.S. reopens to vaccinated travelers from 33 countries after 18 months, as global tally of COVID-19 cases tops 250 millionThe global tally of confirmed cases of the coronavirus-borne illness COVID-19 topped 250 million on Monday, according to data aggregated by Johns Hopkins University, as the U.S. reopened to vaccinated travelers from 33 countries after 18 months of restrictions.
2:41 a.m. Nov. 8, 2021
- By Jaimy Lee
Regeneron says its COVID-19 antibody cocktail can prevent COVID-19 infections for months Shares of Regeneron Pharmaceuticals Inc. gained 3.7% in premarket trading on Monday after the company said four subcutaneous injections of its monoclonal antibody treatment protected unvaccinated people from contracting COVID-19 by 81.6% for up to eight months. Four infusions of the treatment are considered one dose. "These results demonstrate that REGEN-COV has the potential to provide long-lasting immunity from SARS-CoV-2 infection, a result particularly important to those who do not respond to COVID-19 vaccines including people who are immunocompromised," Dr. Myron Cohen, a physician in charge of the National Institutes of Health's work on monoclonal antibodies, said in a news release. Regeneron has already shared similar data in a published in the New England Journal of Medicine but this is a new analysis of that data, which came from a trial assessing giving the treatment to one household member if another was sick to see if it could prevent testing positive for the virus. The results came from 1,684 people who participated in the Phase 3, randomized, placebo-controlled trial. Regeneron's therapy is currently authorized as a treatment for people who are at high risk of severe disease and post-exposure prophylaxis for high-risk people who have been exposed to the virus. Regeneron's stock is up 26.6% so far this year, while the broader S&P 500 has gained 25.1%.
8:53 a.m. Nov. 6, 2021
- By Alessandra Malito
Working and expected to be a family caregiver? 3 ways to protect yourselfMore people take on the responsibility of caring for older family members, but it can cost them money, time and lead to increased stress
5:14 a.m. Nov. 6, 2021
3 Ways to Protect Yourself if You're Working and Expected to Be a Family Caregiver
Here's what to know.
9:24 a.m. Nov. 4, 2021
- By Elisabeth Buchwald
Kids age 5 to 11 can now get
Pfizer's COVID-19 vaccine — 5 key questions parents should ask'Most children will not have symptoms severe enough that they need to miss school,' said a pediatric infectious disease specialist with the Mayo Clinic Children’s Center.
6:12 a.m. Nov. 4, 2021
- By Andrew Keshner
Can kids 5-11 get a flu shot and Pfizer's COVID-19 vaccine at the same time? Here's what doctors sayThe CDC's final approval for Pfizer and BioNTech's vaccine for 5 to 11-year-olds comes as flu season is about to hit full swing.
5:01 a.m. Nov. 4, 2021
A Step in the Right Direction for Sharing Covid-19 Medicines
Merck's Covid-19 pill was just approved in the U.K. The company's agreement with a patent-sharing pool is a model for medical equity, writes Ellen 't Hoen, the pool's founder.
12:30 p.m. Nov. 3, 2021
House Democrats add SALT relief, paid leave, immigration changes to social-spending billHouse Democrats added paid family and medical leave, immigration law changes and a state-and-local tax break to their $1.75 trillion social services and environmental bill Wednesday, reviving some key elements of President Joe Biden’s agenda as they rush to finish the package after dismal overnight election results.
3:56 a.m. Nov. 3, 2021
28 Million Children Are Eligible for Covid Vaccines
The Centers for Disease Control and Prevention signed off Tuesday night on a sweeping recommendation of Pfizer's vaccine for children 5 to 11 years old.
3:11 p.m. Nov. 2, 2021
CDC Recommends Pfizer Covid Vaccine for Kids 5 to 11
It is the first Covid vaccine to be available for kids under 12 in the U.S.
4:27 a.m. Nov. 2, 2021
The Supreme Court Allowed a Key Aspect of Vaccine Mandates to Stand. That May Not Last Forever.
Religious exemptions are at the heart of political fights over vaccine mandates. The court may be wavering on them.
1:43 a.m. Nov. 1, 2021
- By Ciara Linnane
Newsweek cover on vaccines for children slammed by health experts: 'Why not add a foot-long needle for good measure?'A Newsweek cover seeking to illustrate the concerns that some American parents have expressed about their children being vaccinated against COVID-19 has met with sharp criticism from health experts and nonexperts alike.
6:28 a.m. Oct. 31, 2021
Earth gets hotter, deadlier during decades of climate talksWorld leaders have been meeting for 29 years to try to curb global warming, and in that time Earth has become a much hotter and deadlier planet.
12:40 p.m. Oct. 30, 2021
Should you move in your 50s or 60s? How to choose where to live in retirementThe author of 'Right Place Right Time' has some smart ideas to help you answer two critical
questions about where to live in the second half of life.
1:42 a.m. Oct. 27, 2021
Twitter and Alphabet Bat Away Fears Over Apple’s Privacy Setting
Democrats scramble for ways to fund social spending and climate bill, FDA advisors recommend Covid-19 vaccines for children 5 to 11, China Telecom banned from U.S. market, and other news to start your day.
2:09 p.m. Oct. 26, 2021
FDA Panel Backs Pfizer's Covid Vaccine for Children
Vote comes even as committee members raise concerns about the risk of side effects.
2:36 a.m. Oct. 25, 2021
Deadly bacteria found in Walmart aromatherapy spray linked to 2 U.S. deathsU.S. health officials may have solved the mystery of how four people in different states came down with a serious tropical disease even though none had traveled internationally: an aromatherapy spray imported from India.